NCT01254669

Brief Summary

In the United States, Black women are more likely to die of cervical cancer than White women. In developing countries and globally, Haitian immigrant women are more likely to die of cervical cancer than any other women in the world. Studies have shown a disparity in parental acceptance of the HPV vaccine with parents of Black adolescent girls being less likely to accept and comply with HPV immunization schedules than Whites. The objective of this study is to increase HPV immunization rates in Haitian and African American adolescent girls. The investigator's hypothesis is that a validated behavior change mechanism, brief-negotiating interviewing (BNI), will effectively increase the proportion of mothers who give consent for their daughters' HPV vaccine, which will ultimately lead to higher vaccination rates, and increase knowledge of HPV infection and the vaccine in Haitian immigrant and African American mothers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2011

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2010

Completed
4 months until next milestone

First Posted

Study publicly available on registry

December 6, 2010

Completed
26 days until next milestone

Study Start

First participant enrolled

January 1, 2011

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2013

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
8 months until next milestone

Results Posted

Study results publicly available

October 24, 2014

Completed
Last Updated

May 19, 2017

Status Verified

April 1, 2017

Enrollment Period

2.8 years

First QC Date

July 28, 2010

Results QC Date

July 31, 2014

Last Update Submit

April 11, 2017

Conditions

Keywords

Haitian girls, African American girlsBrief Negotiated Interviewcognitive behavioral interventionHPV vaccinecervical cancer

Outcome Measures

Primary Outcomes (1)

  • The Receipt of the First HPV Vaccination

    Receipt of the first HPV vaccination among adolescent daughters of the participants

    within 1 month of randomization

Secondary Outcomes (1)

  • The Secondary Outcome Will be Maternal Knowledge About HPV Vaccine.

    1 hour after intervention

Study Arms (2)

control, standard of care

NO INTERVENTION

Mothers assigned to the Control Group received the low-literacy, standard-practice, HPV-vaccine information sheet

BNI-brief Negotiated Interview

EXPERIMENTAL

The BNI intervention addressed mothers' beliefs, values, and concerns about HPV prevention and takes their priorities for health and well-being into account.

Behavioral: BNI-brief Negotiated Interview

Interventions

use of a cognitive behavioral intervention to improve uptake of HPV vaccine

Also known as: brief intervention to improve HPV vaccine in girls
BNI-brief Negotiated Interview

Eligibility Criteria

Age11 Years - 15 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • HPV vaccine eligible adolescent girls

You may not qualify if:

  • Prior receipt of the HPV vaccine
  • pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston Medical Center

Boston, Massachusetts, 02118, United States

Location

MeSH Terms

Conditions

Uterine Cervical Neoplasms

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Limitations and Caveats

Limitations:small sample,Enrolling only mothers, of daughters who are African-American and Haitians lead to longer recruitment time/non-generalizable data. Future studies should include heterogeneous ethnicities,fathers, sons, and any legal guardian.

Results Point of Contact

Title
Dr. Natalie Joseph
Organization
Boston Medical Center

Study Officials

  • natalie joseph, MD, MPH

    Boston Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 28, 2010

First Posted

December 6, 2010

Study Start

January 1, 2011

Primary Completion

October 1, 2013

Study Completion

March 1, 2014

Last Updated

May 19, 2017

Results First Posted

October 24, 2014

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will not share

Locations